Le Lézard
Classified in: Health
Subjects: SBS, MAT

Canna Hemptm's Proprietary Blend of Terpenes Sets Them Apart in the CBD Industry


FORT LAUDERDALE, Fla., May 21, 2020 /PRNewswire/ -- Nevada-based brand Canna Hemptm has been touted as a CBD company to watch in 2020, but what makes Canna Hemptm's products so unique?

Canna Hemptm has been setting the standard for high-quality CBD wellness products since its inception in 2016, releasing specialty lines that run the gamut from tinctures and capsules to topical creams and beauty products. Canna Hemptm has also released a niche product line, Canna Hemptm X, which is specifically geared towards consumers leading an active lifestyle, with balms, creams and elixirs intended for use after intense exercise.

One of the company's most interesting selling points is that many of their products are made utilizing their own proprietary blend of terpenes, TerpFXtm, which are designed to mimic profiles of cannabis strains, producing various effects. These terpenes work in tandem with the CBD in Canna Hemptm's products to enhance the user experience.

Terpenes are aromatic oils found in the same glands of the cannabis plant that produce the chemicals (called cannabinoids) THC and CBD. While both CBD and THC are used as health products, CBD does not produce the feeling of being "high" that is generally associated with cannabis products. For this reason, Canna Hemptm's products are non-psychoactive and can be taken by anyone.

Terpenes are a major component in the differing effects of various cannabis strains, and different terpenes are associated with different benefits, qualities, and distinctive flavor and scent profiles. Terpenes likely evolved in the cannabis plant for the same reason that many flowering plants have a distinctive odor, to attract pollinators.

Terpenes are the reason why different strains of cannabis smell and taste different from one another. For example, a few common flavors produced by terpenes might have the qualities of "mint," or "citrus," or even "blueberry."  Scientists have identified over 100 different types of terpenes, all with their own individual effects.

Creating their own proprietary blend of terpenes allows Canna Hemptm a greater range of diversity in their products, and greater control over the final outcome of each product they develop, unlike many other CBD products on the market. The brand's adherence to the strictest level of quality control has helped them to stand out as a trusted name in the CBD industry. Canna Hemptm manufactures consistently high-quality products with well-sourced ingredients, which has set them up for success as they continue their brand expansion throughout 2020.

Please direct inquiries to:
Craig Thaice
(561) 384-8736
[email protected] 

SOURCE Canna Hemp


These press releases may also interest you

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
DexCom, Inc. today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an...

at 16:05
Ironwood Pharmaceuticals, Inc. today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in participating in the call should dial (888)...



News published on and distributed by: